Schrödinger raised $85m from investors including WuXi AppTec and GV and will use the money to expand the capabilities of its drug discovery software.

WuXi AppTec has co-led an $85m funding round for US-based molecular-simulation software developer Schrödinger through its Corporate Venture Fund. Bill and Melinda Gates Foundation Trust, the endowment arm of philanthropic organisation Bill and Melinda Gates Foundation, co-led the round, which included GV, an early-stage investment subsidiary of internet and technology conglomerate Alphabet. Asset management firm…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.